Venaxis Announces Proposed Public Offering of Common Shares; Size Undisclosed
April 02, 2014 at 16:01 PM EDT
Venaxis, Inc. (NASDAQ: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked ...